ERBB2 and neoplasm: These observations confirm that c-Src supports OXPHOS capacity in ErbB2+ breast cancer cells, while arguing that metabolic reprogramming towards enhanced glycolysis is an adaptation that occurs during tumor evolution in the absence of c-Src.